Streamex Corp. (STEX): Total Liabilities
$54.22M
As of 2025-12-31
$12.37M
As of 2026-06-30
+144.4%
3-year compound annual growth
+60.4%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $54.22M | n/m | 2026-03-31, Balance as of period end |
| 2024-12-31 | $2.26M | -51.7% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $4.68M | +26.2% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $3.71M | +25.7% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $2.95M | -42.2% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $5.11M | n/a | 2022-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Streamex Corp. (STEX) | 2025-12-31 | $54.22M | n/m |
| Ceribell, Inc. (CBLL) | 2025-12-31 | $40.47M | +18.2% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $92.84M | -7.0% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $137.54M | -44.8% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $34.00M | -32.8% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $12.29M | +16.0% |
| Hongchang International Co., Ltd (HCIL) | 2024-12-31 | $18.68M | +92.0% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $14.26M | +44.6% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $33.53M | -5.0% |
Compare STEX, CBLL, AXGN, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗